Literature DB >> 31667772

Quantitation of Molecular Pathway Activation Using RNA Sequencing Data.

Nicolas Borisov1,2, Maxim Sorokin1,2,3, Andrew Garazha2, Anton Buzdin4,5,6.   

Abstract

Intracellular molecular pathways (IMPs) control all major events in the living cell. IMPs are considered hotspots in biomedical sciences and thousands of IMPs have been discovered for humans and model organisms. Knowledge of IMPs activation is essential for understanding biological functions and differences between the biological objects at the molecular level. Here we describe the Oncobox system for accurate quantitative scoring activities of up to several thousand molecular pathways based on high throughput molecular data. Although initially designed for gene expression and mainly RNA sequencing data, Oncobox is now also applicable for quantitative proteomics, microRNA and transcription factor binding sites mapping data. The Oncobox system includes modules of gene expression data harmonization, aggregation and comparison and a recursive algorithm for automatic annotation of molecular pathways. The universal rationale of Oncobox enables scoring of signaling, metabolic, cytoskeleton, immunity, DNA repair, and other pathways in a multitude of biological objects. The Oncobox system can be helpful to all those working in the fields of genetics, biochemistry, interactomics, and big data analytics in molecular biomedicine.

Entities:  

Keywords:  Big data analytics; Bioinformatics; Biomarkers; Cancer; Epigenetics; Gene expression; Intracellular molecular pathways; Machine learning; Micro-RNA; Proteomics; Systems biology; Transcriptomics; miR

Year:  2020        PMID: 31667772     DOI: 10.1007/978-1-0716-0138-9_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways.

Authors:  Marianna A Zolotovskaia; Max A Kovalenko; Victor S Tkachev; Alexander M Simonov; Maxim I Sorokin; Ella Kim; Denis V Kuzmin; Betul Karademir-Yilmaz; Anton A Buzdin
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  Reciprocal Dysregulation of MiR-146b and MiR-451 Contributes in Malignant Phenotype of Follicular Thyroid Tumor.

Authors:  Margarita Knyazeva; Ekaterina Korobkina; Alexey Karizky; Maxim Sorokin; Anton Buzdin; Sergey Vorobyev; Anastasia Malek
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

3.  System, Method and Software for Calculation of a Cannabis Drug Efficiency Index for the Reduction of Inflammation.

Authors:  Nicolas Borisov; Yaroslav Ilnytskyy; Boseon Byeon; Olga Kovalchuk; Igor Kovalchuk
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

4.  Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways.

Authors:  Maxim Sorokin; Nicolas Borisov; Denis Kuzmin; Alexander Gudkov; Marianna Zolotovskaia; Andrew Garazha; Anton Buzdin
Journal:  Front Genet       Date:  2021-02-09       Impact factor: 4.599

5.  DNA repair pathway activation features in follicular and papillary thyroid tumors, interrogated using 95 experimental RNA sequencing profiles.

Authors:  Uliana Vladimirova; Pavel Rumiantsev; Marianna Zolotovskaia; Eugene Albert; Aleksander Abrosimov; Konstantin Slashchuk; Petr Nikiforovich; Olga Chukhacheva; Nurshat Gaifullin; Maria Suntsova; Galina Zakharova; Alexander Glusker; Daniil Nikitin; Andrew Garazha; Xinmin Li; Dmitriy Kamashev; Alexei Drobyshev; Irina Kochergina-Nikitskaya; Maxim Sorokin; Anton Buzdin
Journal:  Heliyon       Date:  2021-03-13

6.  COVID-19-associated inhibition of energy accumulation pathways in human semen samples.

Authors:  Leila Adamyan; Vladimir Elagin; Valeriy Vechorko; Assia Stepanian; Anton Dashko; Dmitriy Doroshenko; Yana Aznaurova; Maxim Sorokin; Maria Suntsova; Alexei Drobyshev; Andrew Garazha; Anton Buzdin
Journal:  F S Sci       Date:  2021-08-05

7.  Mutation Enrichment and Transcriptomic Activation Signatures of 419 Molecular Pathways in Cancer.

Authors:  Marianna A Zolotovskaia; Victor S Tkachev; Alexander P Seryakov; Denis V Kuzmin; Dmitry E Kamashev; Maxim I Sorokin; Sergey A Roumiantsev; Anton A Buzdin
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

8.  RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer.

Authors:  Maxim Sorokin; Elena Poddubskaya; Madina Baranova; Alex Glusker; Lali Kogoniya; Ekaterina Markarova; Daria Allina; Maria Suntsova; Victor Tkachev; Andrew Garazha; Marina Sekacheva; Anton Buzdin
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-04-01

Review 9.  FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients.

Authors:  Ye Wang; Zhuang Tong; Wenhua Zhang; Weizhen Zhang; Anton Buzdin; Xiaofeng Mu; Qing Yan; Xiaowen Zhao; Hui-Hua Chang; Mark Duhon; Xin Zhou; Gexin Zhao; Hong Chen; Xinmin Li
Journal:  Front Oncol       Date:  2021-06-07       Impact factor: 6.244

10.  Case of multifocal glioblastoma with four fusion transcripts of ALK, FGFR2, NTRK2, and NTRK3 genes stresses the need for tumor tissue multisampling for transcriptomic analysis.

Authors:  Amir Samii; Maxim Sorokin; Souvik Kar; Luidmila Makovskaia; Andrew Garazha; Christian Hartmann; Aleksey Moisseev; Ella Kim; Alf Giese; Anton Buzdin
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.